Close Menu

Moffitt Cancer Center

The team envisions developing an assay to guide targeted treatment for metastatic castration-resistant prostate cancer patients.   

Health systems' molecular testing labs haven't had to cut back on genomic profiling for cancer patients yet but may need to accommodate COVID-19 testing if needed.

The partnership aims to analyze the differences in the tumor microenvironments of cancer patients and use that to classify tumors and determine treatment prognosis.

Investigators compared expression in different men across the genes from three commercial panels, arguing that the findings highlight important unknowns.

Top cancer centers around the country are starting research autopsy programs in an effort to overcome the blindspots and limitations of current precision oncology approaches. 

A proteogenomic analysis by a Moffitt Cancer Center-led team uncovered three subtypes of squamous cell lung cancer and treatment approaches to investigate.